Intellipharmaceutics Announces First Quarter 2013 Results
03 avr. 2013 17h30 HE
|
Intellipharmaceutics International Inc.
TORONTO, April 3, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Closes US$3.1 Million Registered Direct Offering of Units
25 mars 2013 14h52 HE
|
Intellipharmaceutics International Inc.
TORONTO, March 25, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics to Raise US$3.1 Million
19 mars 2013 09h07 HE
|
Intellipharmaceutics International Inc.
TORONTO, March 19, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Announces Update on Its Generic Versions of Keppra XR(R) and Pristiq(R)
13 mars 2013 18h00 HE
|
Intellipharmaceutics International Inc.
TORONTO, March 13, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Announces 2012 Year End Results
31 janv. 2013 21h52 HE
|
Intellipharmaceutics International Inc.
TORONTO, Jan. 31, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Closes US$1.5 Million Convertible Debenture Financing
10 janv. 2013 17h00 HE
|
Intellipharmaceutics International Inc.
TORONTO, Jan. 10, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Announces Proposed Convertible Debenture Financing
07 janv. 2013 08h00 HE
|
Intellipharmaceutics International Inc.
TORONTO, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...
Intellipharmaceutics Announces Results of Initial Phase I Clinical Trial of Controlled-Release Pregabalin and Product Updates
27 nov. 2012 07h00 HE
|
Intellipharmaceutics International Inc.
TORONTO, Nov. 27, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics to Present at the 24th Annual Piper Jaffray Healthcare Conference
21 nov. 2012 07h00 HE
|
Intellipharmaceutics International Inc.
TORONTO, Nov. 21, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel...
Intellipharmaceutics Announces Third Quarter 2012 Results
02 oct. 2012 17h00 HE
|
Intellipharmaceutics International Inc.
TORONTO, Oct. 2, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and...